6 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #AdverseEvents ... #NEJM #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Pneumonia Severity Index (PSI) as a site-of-care tool. BUN, blood urea nitrogen; CHF, chronic heart failure;
Severity Index (PSI ... pressure #Management #EM ... #IM #Pneumonia ... #Risk #Stratification ... #Criteria
Pneumonia Severity Index (PSI) as a site-of-care tool. BUN, blood urea nitrogen; CHF, chronic heart failure;
Severity Index (PSI ... pressure #Management #EM ... #IM #Pneumonia ... #Risk #Stratification ... #Criteria
Pneumonia Severity Index (PSI)  - The PSI was developed from an administrative data set of
) - The PSI was ... populations #Management #EM ... #IM #Pneumonia ... #Risk #Stratification ... #Criteria #AAFP